Allianz Life Insurance of North America’s iShares Biotechnology ETF IBB Stock Holding History

Allianz Life Insurance of North America’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$3M	Sell	24,617 -1,630	-6%	-$192K	3.28%	7
2018 Q2	$2.88M	Sell	26,247 -179	-0.7%	-$19.1K	3.41%	5
2018 Q1	$2.81M	Buy	26,426 +1,346	+5%	+$149K	3.9%	7
2017 Q4	$2.68M	Buy	25,080 +4,005	+19%	+$428K	5.84%	7
2017 Q3	$2.34M	Buy	21,075 +183	+0.9%	+$19.6K	6.2%	7
2017 Q2	$2.16M	Buy	20,892 +2,667	+15%	+$263K	6.26%	7
2017 Q1	$1.78M	Buy	18,225 +1,584	+10%	+$152K	5.62%	6
2016 Q4	$1.47M	Buy	+16,641	New	+$1.51M	5.13%	6

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allianz Life Insurance of North America's IBB Position: Q3 2018 in Review

Allianz Life Insurance of North America reduced its iShares Biotechnology ETF (IBB) stake by 6.2% in Q3 2018, selling an estimated $192K and leaving 24,617 shares worth $3M. The position accounts for 3.28% of the portfolio, ranked #7.

Allianz Life Insurance of North America first reported a position in IBB in Q4 2016 and has held it in 8 quarters since. 631 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

Allianz Life Insurance of North America held 24,617 shares of iShares Biotechnology ETF worth $3M as of Q3 2018.
Allianz Life Insurance of North America sold 1,630 iShares Biotechnology ETF shares in Q3 2018, an estimated $192K.
iShares Biotechnology ETF made up 3.28% of Allianz Life Insurance of North America's portfolio in Q3 2018, its #7 holding.
Allianz Life Insurance of North America first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 8 quarters since.
631 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on Allianz Life Insurance of North America's 13F filing for Q3 2018, filed 16 Oct 2018.